Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study.

Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, Modai I, Khaikin M, Weizman A.

Br J Psychiatry. 1997 Dec;171:569-73.

PMID:
9519099
2.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
3.

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.

Sommer IE, Begemann MJ, Temmerman A, Leucht S.

Schizophr Bull. 2012 Sep;38(5):1003-11. doi: 10.1093/schbul/sbr004. Epub 2011 Mar 21. Review.

4.

Augmentation with sulpiride for a schizophrenic patient partially responsive to clozapine.

Stubbs JH, Haw CM, Staley CJ, Mountjoy CQ.

Acta Psychiatr Scand. 2000 Nov;102(5):390-3; discussion 393-4. Review.

PMID:
11098812
5.

Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.

Zink M, Knopf U, Henn FA, Thome J.

Pharmacopsychiatry. 2004 Jan;37(1):26-31. Review.

PMID:
14750045
6.

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.

Mouaffak F, Tranulis C, Gourevitch R, Poirier MF, Douki S, Olié JP, Lôo H, Gourion D.

Clin Neuropharmacol. 2006 Jan-Feb;29(1):28-33. Review.

PMID:
16518132
7.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
8.

The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.

Brar JS, Chengappa KN, Parepally H, Sandman AR, Kreinbrook SB, Sheth SA, Ganguli R.

Ann Clin Psychiatry. 1997 Dec;9(4):227-34. Review.

PMID:
9511946
9.

Amisulpride: progress and outcomes.

Lecrubier Y.

Curr Med Res Opin. 2002;18 Suppl 3:s18-22. Review.

PMID:
12418608
10.

Does the addition of a second antipsychotic drug improve clozapine treatment?

Barbui C, Signoretti A, Mulè S, Boso M, Cipriani A.

Schizophr Bull. 2009 Mar;35(2):458-68. doi: 10.1093/schbul/sbn030. Epub 2008 Apr 23. Review.

11.

Clozapine for the treatment of schizophrenia.

Fakra E, Azorin JM.

Expert Opin Pharmacother. 2012 Sep;13(13):1923-35. doi: 10.1517/14656566.2012.709235. Epub 2012 Jul 18. Review.

PMID:
22803789
12.

Schizophrenia.

Freedman R.

N Engl J Med. 2003 Oct 30;349(18):1738-49. Review. No abstract available.

PMID:
14585943
13.

A risk-benefit assessment of sulpiride in the treatment of schizophrenia.

Mauri MC, Bravin S, Bitetto A, Rudelli R, Invernizzi G.

Drug Saf. 1996 May;14(5):288-98. Review.

PMID:
8800626
14.

Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.

Veerman SR, Schulte PF, Begemann MJ, de Haan L.

Pharmacopsychiatry. 2014 Nov;47(7):231-8. doi: 10.1055/s-0034-1385930. Epub 2014 Aug 14. Review.

PMID:
25121994
15.

Clozapine. A novel antipsychotic agent.

Baldessarini RJ, Frankenburg FR.

N Engl J Med. 1991 Mar 14;324(11):746-54. Review. No abstract available.

PMID:
1671793
16.

Sulpiride augmentation for schizophrenia.

Wang J, Omori IM, Fenton M, Soares B.

Schizophr Bull. 2010 Mar;36(2):229-30. doi: 10.1093/schbul/sbp163. Epub 2010 Jan 8. Review. No abstract available.

17.

Patient response and resource management: another view of clozapine treatment of schizophrenia.

Carpenter WT Jr, Conley RR, Buchanan RW, Breier A, Tamminga CA.

Am J Psychiatry. 1995 Jun;152(6):827-32. Review.

PMID:
7755110
18.

Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.

Veerman SR, Schulte PF, Begemann MJ, Engelsbel F, de Haan L.

Pharmacopsychiatry. 2014 Sep;47(6):185-94. doi: 10.1055/s-0034-1383656. Epub 2014 Jul 7. Review.

PMID:
25002291
19.

Drug treatment of schizophrenia.

Silverstone T.

N Z Med J. 1994 Apr 27;107(976):145-6. Review. No abstract available.

PMID:
7909363
20.

Sulpiride: an antipsychotic with selective dopaminergic antagonist properties.

Caley CF, Weber SS.

Ann Pharmacother. 1995 Feb;29(2):152-60. Review.

PMID:
7756714

Supplemental Content

Support Center